Medical Education
Medical Information and Sources
Semaglutide and tirzepatide are prescription drug ingredients. Specific branded products have specific FDA-approved indications, dosing instructions, warnings, and contraindications. A licensed clinician must determine whether any treatment is appropriate for an individual patient.
Core Sources
- FDA prescribing information for Wegovy, semaglutide
- FDA prescribing information for Zepbound, tirzepatide
- FDA chronic weight-management approval information for tirzepatide
- NIDDK guide to prescription medications for overweight and obesity
- NIDDK guide to choosing a safe weight-loss program
- CDC adult BMI categories and interpretation
- FDA concerns about unapproved GLP-1 products used for weight loss
How to Use This Information
Use these sources to prepare questions for a licensed healthcare professional. Do not use website information or calculator output to select a drug, determine a dose, assess contraindications, or respond to side effects.
Emergency and Safety Questions
For urgent symptoms or a possible emergency, call 911 or seek immediate emergency care. For medication-specific safety questions, contact the prescribing clinician or pharmacist and consult the current FDA-approved prescribing information.